Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma.
Saved in:
| Title: | Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma. |
|---|---|
| Authors: | D'Angelo SP; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA. dangelos@mskcc.org.; Department of Medicine, Weill Cornell Medical College, New York City, NY, USA. dangelos@mskcc.org.; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York City, NY, USA. dangelos@mskcc.org., Richards AL; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Conley AP; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Woo HJ; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Dickson MA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York City, NY, USA., Gounder M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York City, NY, USA., Kelly C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York City, NY, USA., Keohan ML; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York City, NY, USA., Movva S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York City, NY, USA., Thornton K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York City, NY, USA., Rosenbaum E; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York City, NY, USA., Chi P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York City, NY, USA., Nacev B; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York City, NY, USA.; Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York City, NY, USA., Chan JE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Slotkin EK; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Kiesler H; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Adamson T; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Ling L; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Rao P; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Patel S; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Livingston JA; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Singer S; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Agaram NP; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Antonescu CR; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Koff A; Program in Molecular Biology, Memorial Sloan Kettering Cancer, New York City, NY, USA., Erinjeri JP; Department of Interventional Radiology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Hwang S; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Qin LX; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Donoghue MTA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Tap WD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York City, NY, USA. |
| Source: | Nature communications [Nat Commun] 2022 Jun 16; Vol. 13 (1), pp. 3477. Date of Electronic Publication: 2022 Jun 16. |
| Publication Type: | Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-022-30874-8 |
